The world’s most expensive drugs can’t cure the ills of this biotech

Bluebird Organic is poised to become the seller of the two most expensive drugs in the United States, and by extension the world, each grossing nearly $3 million.

While the high price is already causing a backlash from the public, one would think that the company and its investors would at least see a huge payoff when the drugs finally hit the market. Not enough. Two Food and Drug Administration approvals last summer might have saved the company from financial abyss, but Boston-area-based Bluebird, which announced deep cost cuts in April to stay at afloat, will run out of money for a while.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button